HB 1326
In CommitteeHouse
Diabetes and obesity
Concerning the diabetes prevention and obesity treatment act.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires health insurers and Medicaid to cover a full range of obesity treatments—including behavioral therapy, weight-loss medications, and surgery—as essential health benefits, ensuring equal coverage rules and access as other medical conditions. It also sets a deadline for the state to apply for federal funding to support Medicaid coverage.
- Starting January 1, 2026, health insurers must cover diagnosis and treatment of obesity—including intensive behavioral/lifestyle programs, FDA-approved weight-loss medications, and metabolic and bariatric surgery—on par with coverage for other medical conditions.
- Coverage rules for weight-loss medications cannot be stricter than the FDA’s approved uses, and insurers cannot impose separate or higher deductibles/copays for obesity treatments.
- Medicaid (managed care plans) must also cover these obesity treatments after the state applies for and receives federal approval and matching funds by November 1, 2025.
- Utilization management (like prior authorization) is allowed, but only if applied the same way as for other medical treatments.
- Intensive behavioral treatment can include CDC-certified or clinically recommended programs and can be delivered in person or via telemedicine.
Who is affected
- People with obesity or weight-related health concerns — People with obesity or at risk for obesity who have Washington-based health insurance (including individual, employer-sponsored, and Medicaid plans) will gain access to covered treatments like behavioral therapy, weight-loss medications, and surgery without extra cost-sharing barriers.
- Health insurers and Medicaid managed care organizations — Health insurance companies (including private insurers and Medicaid managed care organizations) must cover obesity treatments as part of standard health benefits and apply coverage rules consistently with other medical conditions.
- Washington State Health Care Authority and Department of Social and Health Services — State agencies like the Health Care Authority will need to apply for federal funding and ensure Medicaid-covered services include obesity treatment options.
- Healthcare providers treating obesity — Healthcare providers (doctors, surgeons, dietitians, behavioral health specialists) will be able to bill for covered obesity treatments and follow standardized coverage rules.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Mandating comprehensive obesity coverage—including FDA-approved medications, behavioral therapy, and surgery—without extra cost-sharing removes a major barrier for low- and middle-income Washingtonians with obesity, many of whom delay or forgo care due to out-of-pocket costs, leading to improved health outcomes and earlier intervention.
HealthcarePeopleRef: Sec. 1(1) & Sec. 3(2)Prohibiting separate or higher deductibles/copays for obesity care aligns coverage with other chronic conditions, reducing stigma and ensuring equitable access—particularly for Medicaid enrollees and working families who face financial toxicity from fragmented coverage rules.
HealthcarePeopleRef: Sec. 1(3) & Sec. 3(4)State application for federal Medicaid matching funds (up to 63% FMAP in 2025) significantly reduces the net fiscal burden on state budgets, making coverage expansion fiscally responsible and expanding access to care for low-income Washingtonians who are disproportionately affected by obesity.
FinancialPeopleRef: Sec. 3(1)While short-term spending may rise, long-term savings from preventing or mitigating obesity-related complications (e.g., type 2 diabetes, cardiovascular disease, joint surgery) could reduce overall healthcare costs—especially for publicly funded programs like Medicaid and Medicare, where obesity comorbidities drive high utilization.
HealthcarePeopleRef: Fiscal Impact SummaryInclusion of CDC-certified or clinically recommended intensive behavioral programs—delivered via telemedicine—expands access to preventive care, especially for rural, elderly, and mobility-limited patients, supporting early intervention before costly acute care is needed.
HealthcareLean peopleRef: Sec. 1(5) & Sec. 3(5)
Potential Concerns (5)
The bill prohibits insurers from imposing separate or higher deductibles/copays for obesity treatments, which may reduce their ability to manage utilization and increase premium costs for all enrollees—especially in small-group and individual markets—though federal Medicaid matching funds offset some state costs.
FinancialLean industryRef: Sec. 1(3)While utilization management is permitted, the requirement that it be applied identically to obesity as to other conditions may reduce insurers’ flexibility to apply cost-containment tools (e.g., step therapy, narrow networks), potentially increasing administrative and claims-processing costs for insurers—costs often passed to employers and large-group plan sponsors.
Business & EmploymentIndustryRef: Sec. 1(4) & Sec. 3(4)The prohibition on more restrictive coverage criteria for FDA-approved medications may require insurers to cover off-label uses or higher-cost branded drugs earlier than clinically necessary, increasing drug spending and potentially premium costs—particularly for self-insured employers who bear direct costs.
Business & EmploymentIndustryRef: Sec. 1(2)By incorporating obesity coverage into the state employee health plan (SEH), the bill may increase state expenditures for SEH, potentially diverting funds from other priorities or requiring premium increases for state employees—especially those in higher-income brackets who are less likely to qualify for subsidies.
FinancialLean industryRef: Sec. 2 (reenacting RCW 41.05.017)Allowing telemedicine delivery of intensive behavioral treatment expands access but may strain existing digital infrastructure in rural or low-income areas, where broadband access and health literacy are lower—potentially widening disparities despite well-intentioned policy.
HealthcareRef: Sec. 1(5) & Sec. 3(5)
Who Is Most Affected
Low- and middle-income Washingtonians with obesity—especially those on Medicaid or working in low-wage jobs—gain direct access to evidence-based treatments without extra cost-sharing, improving health equity and reducing out-of-pocket burden. However, those without insurance or in non-covered plans (e.g., short-term, grandfathered) may not benefit.
Large commercial insurers and Medicaid managed care organizations face new coverage mandates but benefit from federal matching funds and standardized utilization management rules. Smaller insurers and self-insured employers may face higher administrative and claims costs without proportional economies of scale.
State agencies gain federal funding to expand coverage but must invest staff and systems to implement new billing, prior authorization, and provider network requirements. This could strain agency resources short-term, though long-term savings from reduced chronic disease burden may offset costs.
Primary care providers, bariatric surgeons, dietitians, and behavioral health specialists gain new billing opportunities and reduced administrative barriers to treating obesity. However, providers in safety-net clinics may face capacity constraints due to increased demand without proportional reimbursement increases.
Employers—especially those with self-insured plans—may see modest premium increases or administrative costs, but could benefit from reduced absenteeism and improved productivity if obesity-related disability declines. Small businesses may lack the bargaining power to offset rising plan costs.